KemPharm, Inc.
Hedge Funds Holdings
Last updated:
KemPharm, Inc.‘s stocks are currently a part of 59 hedge funds’ portfolios, which represents 21.97% of the total amount of its stocks outstanding. This makes up a total of 6.53M shares of KemPharm, Inc.. Compared to the previous quarter, the number fell by -9.98% or -725.04K shares fewer. As for the holding position changes, 22.03% (13) of current hedge fund investors increased the number of shares held, 40.68% (24) of current holders sold a part of the shares held, and 11.86% (7) closed the holdings completely. 6 hedge funds are new holders of KemPharm, Inc. stock in Q3 2022, it is 10.17% of total holders.
Hedge funds holding KemPharm (Q4 2017 – Q3 2022)
| Q4 2017 | 27 |
|---|---|
| Q1 2018 | 34 |
| Q2 2018 | 40 |
| Q3 2018 | 32 |
| Q4 2018 | 37 |
| Q1 2019 | 37 |
| Q2 2019 | 31 |
| Q3 2019 | 34 |
| Q4 2019 | 24 |
| Q1 2020 | 26 |
| Q2 2020 | 6 |
| Q3 2020 | 2 |
| Q4 2020 | 2 |
| Q1 2021 | 49 |
| Q2 2021 | 68 |
| Q3 2021 | 69 |
| Q4 2021 | 74 |
| Q1 2022 | 76 |
| Q2 2022 | 65 |
| Q3 2022 | 59 |
Hedge funds changes in KemPharm positions (Q4 2017 – Q3 2022)
| Q4 2017 | 5 | 6 | 8 | 2 | 6 |
|---|---|---|---|---|---|
| Q1 2018 | 12 | 10 | 5 | 5 | 2 |
| Q2 2018 | 10 | 14 | 9 | 4 | 3 |
| Q3 2018 | 7 | 5 | 9 | 15 | -4 |
| Q4 2018 | 10 | 15 | 4 | 5 | 3 |
| Q1 2019 | 6 | 9 | 8 | 6 | 8 |
| Q2 2019 | 3 | 7 | 7 | 9 | 5 |
| Q3 2019 | 7 | 8 | 4 | 3 | 12 |
| Q4 2019 | 1 | 4 | 8 | 11 | 0 |
| Q1 2020 | 9 | 5 | 5 | 5 | 2 |
| Q2 2020 | 2 | 1 | 0 | 22 | -19 |
| Q3 2020 | 0 | 0 | 0 | 4 | -2 |
| Q4 2020 | 1 | 0 | 0 | 1 | 0 |
| Q1 2021 | 47 | 1 | 0 | 0 | 1 |
| Q2 2021 | 35 | 12 | 9 | 16 | -4 |
| Q3 2021 | 13 | 24 | 16 | 11 | 5 |
| Q4 2021 | 17 | 27 | 16 | 13 | 1 |
| Q1 2022 | 17 | 22 | 19 | 12 | 6 |
| Q2 2022 | 12 | 14 | 29 | 24 | -14 |
| Q3 2022 | 6 | 13 | 24 | 7 | 9 |
Hedge funds changes in KemPharm stock options (Q4 2017 – Q3 2022)
| Q4 2017 | 0 | 0 |
|---|---|---|
| Q1 2018 | 28,000 | 0 |
| Q2 2018 | 8,000 | 0 |
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 2,000 |
| Q1 2019 | 29,000 | 64,000 |
| Q2 2019 | 49,000 | 0 |
| Q3 2019 | 13,000 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 19,314,000 | 9,137,000 |
| Q2 2021 | 30,609,000 | 13,716,000 |
| Q3 2021 | 19,950,000 | 6,773,000 |
| Q4 2021 | 19,183,000 | 11,829,000 |
| Q1 2022 | 6,612,000 | 6,544,000 |
| Q2 2022 | 5,467,000 | 5,926,000 |
| Q3 2022 | 6,345,000 | 9,321,000 |